Trials / Conditions / Hematologic Disease

Hematologic Disease

17 registered clinical trials studyying Hematologic Disease — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	UNIVERSAL GENETIC TESTING OF PATIENTS WITH HEMATOLOGICAL MALIGNANCIES (UGT) NCT06843291	Augusta University	N/A
Active Not Recruiting	Precise Design of Cell Therapy for Relapsed and Refractory Hematological Tumors NCT06849921	Ruijin Hospital	N/A
Recruiting	Human Leukocyte Antigen (HLA) Mismatched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation NCT06809712	He Huang	Phase 1
Unknown	Retrospective Non-interventional Analysis of Opportunistic Infections in Immunocompromised and Frail Patients NCT03920735	University Hospital, Strasbourg, France	—
Completed	Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®) NCT03013439	Pharmacosmos A/S	Phase 1
Completed	Randomized Controlled Trial Comparing a Conservative Management and Laser Surgery NCT01220011	Assistance Publique - Hôpitaux de Paris	N/A
Completed	Pharmaco-economic Study of a New Medical Device Performed From the Perspective of the Hospital NCT01426295	Nantes University Hospital	Phase 2
Completed	Safety of Catheter Lock With or Without Heparin in Implanted Central Venous Catheters NCT00994136	Universitaire Ziekenhuizen KU Leuven	Phase 4
Completed	Radiologic Features of Invasive Pulmonary Aspergillosis NCT01178177	Asan Medical Center	—
Completed	Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe NCT00782470	Bayer	—
Completed	BAY14-2222 Prophylaxis and Joint Function Improvement (Adults) NCT00586521	Bayer	Phase 4
Completed	Early Application of CPAP in Hematologic NCT00507533	University of Turin, Italy	Phase 4
Completed	Functional Evaluation of Two Types of Totally Implanted Venous Ports NCT00484848	Universitaire Ziekenhuizen KU Leuven	N/A
Completed	Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With NCT00168090	CSL Behring	Phase 4
Completed	Treatment and Management of Women With Bleeding Disorders NCT00111215	Centers for Disease Control and Prevention	N/A
Completed	Medical Treatment for Diamond Blackfan Anemia NCT00001749	National Heart, Lung, and Blood Institute (NHLBI)	Phase 2
Completed	Evaluation of Patients With Blood Disorders NCT00001715	National Institutes of Health Clinical Center (CC)	—